Streetbeat News

Products Services

PTCT

PTC Therapeutics, Inc. (NASDAQ:PTCT) announced that the Committee for Medicinal Products for Human Use (CHMP) has recommended the extension of the Evrysdi marketing authorization to include infants under two months of age in the EU. A final decision is expected from the European Commission later this year. Evrysdi is marketed by Roche and in the United States by Genentech, a member of the Roche Group.

Portfolio Pulse from Happy Mohamed

July 21, 2023 | 1:31 pm

PTON

Peloton has reduced the price of its Tread and Row devices by $500 and $200 respectively. The new prices are not sale prices but permanent ones. The price of the Peloton Bike, Bike+, and Guide remains unchanged. Customers who purchased the Tread or Row in the last 30 days can reach out to Peloton for a price match. The price drop is effective in the US and Canada. This is the first price change for the Tread in nearly a year and the third since Barry McCarthy became CEO. No reason was given for the price changes.

Portfolio Pulse from Happy Mohamed

July 21, 2023 | 1:29 pm

GOOG

GOOGL

MSFT

Alphabet Inc's Google stock is trading higher amid reports of co-founder Sergey Brin increasing his involvement in the company's AI research. Brin is actively participating in meetings about AI and working closely with researchers developing Google's AI model, Gemini. His involvement is viewed positively by researchers. Brin's return coincides with the release of ChatGPT, an AI chatbot by Microsoft-backed OpenAI, which prompted Google to accelerate product development.

Portfolio Pulse from Anusuya Lahiri

July 21, 2023 | 1:27 pm

IXHL

Incannex Healthcare Limited (NASDAQ:IXHL) has submitted an Investigational New Drug (IND) application to the US Food and Drug Administration (FDA) for IHL-42X, a treatment for obstructive sleep apnoea. The IND application includes comprehensive information on the safety and efficacy of IHL-42X, as well as details on the development, manufacturing, quality, and stability of the drug product. The application also outlines the clinical trial protocol for a multi-site phase 2/3 clinical trial investigating IHL-42X.

Portfolio Pulse from Happy Mohamed

July 21, 2023 | 1:10 pm

TRMB

Trimble has launched a new cloud-based version of its Log Inventory and Management System (LIMS) for forestry. The new Trimble LIMS PRO is aimed at small- and medium-sized companies, offering them the opportunity to realize productivity and growth gains.

Portfolio Pulse from Benzinga Newsdesk

July 21, 2023 | 12:47 pm

CBAT

CBAK Energy Technology, Inc. (NASDAQ:CBAT) has announced strategic collaborations in Shangqiu City, China, to expand its battery production capacities. The collaborations involve investment and lease agreements that will allow CBAK Energy to meet the increasing demand for its 26700 cylindrical batteries at a lower cost. The company's subsidiary, Dalian CBAK, will pay an annual rental to use the Lessor's production line, which is expected to increase Dalian CBAK's capacity by approximately RMB300 million worth of batteries. The Lessor will cover the costs of renovating the production line, and production is expected to start this year.

Portfolio Pulse from Happy Mohamed

July 21, 2023 | 12:30 pm

WLDS

Wearable Devices Ltd. (NASDAQ:WLDS) has launched a licensing program for its Mudra gesture technology. The program allows original equipment manufacturers to customize the company's technology to meet their specific needs. The move is expected to significantly expand the company's addressable market by enabling businesses to develop their own co-branded touchless control products.

Portfolio Pulse from Happy Mohamed

July 21, 2023 | 12:19 pm

JAZZ

The European Medicines Agency's CHMP has recommended the approval of Jazz Pharmaceuticals' JZP458 for use as a component of a multi-agent chemotherapeutic regimen for acute lymphoblastic leukemia, lymphoblastic lymphoma.

Portfolio Pulse from Benzinga Newsdesk

July 21, 2023 | 12:12 pm

WIMI

WiMi Hologram Cloud Inc. has developed a humanoid robot control system based on a head-mounted display (HMD) controlled by a brain-computer interface (BCI). The system allows interaction with the environment and humans, providing real-time feedback through the robot's embedded camera.

Portfolio Pulse from Benzinga Newsdesk

July 21, 2023 | 12:10 pm

NVCR

Novocure has received a positive recommendation from an independent data monitoring committee to continue its Phase 3 PANOVA-3 trial. The trial is evaluating the effectiveness of Tumor Treating Fields Therapy in treating pancreatic cancer.

Portfolio Pulse from Benzinga Newsdesk

July 21, 2023 | 12:02 pm